Last Updated: November 9, 2026

LIDEX-E Drug Patent Profile

Name: LIDEX-E Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Lidex-e patents expire, and when can generic versions of Lidex-e launch?

Lidex-e is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in LIDEX-E is fluocinonide. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lidex-e

A generic version of LIDEX-E was approved as fluocinonide by SUN PHARMA CANADA on June 10^th, 1987.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LIDEX-E?
What are the global sales for LIDEX-E?
What is Average Wholesale Price for LIDEX-E?

Summary for LIDEX-E

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	73
Patent Applications:	4,786
DailyMed Link:	LIDEX-E at DailyMed

Drug patent expirations by year for LIDEX-E

US Patents and Regulatory Information for LIDEX-E

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	LIDEX-E	fluocinonide	CREAM;TOPICAL	016908-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for LIDEX-E

See the table below for patents covering LIDEX-E around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Belgium	737875		⤷ Start Trial
Canada	989304	FATTY ALCOHOL - PROPYLENE GLYCOL VEHICLE	⤷ Start Trial
Switzerland	516312	Arneimittelgrundlage zur lokalen Anwendung therapeutischer Wirkstoffe	⤷ Start Trial
Germany	1934334		⤷ Start Trial
Denmark	124857		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.